Skip to content

EPLR 2/2020

The second issue of the European Pharmaceutical Law Review in the 2020 is now available. The issue features an article on the price control of publicly financed medicinal products in Slovenia as well case notes on the recent Avastin decision and the judgment concerning the legitimacy of patent settlement agreements within the EU competition law framework. The issue also features our special series on the regulatory response to the Covid – 19 pandemic:


As well as updates on the most recent court decisions and the latest policy developments, the issue also features a review of Matthias Herdegen’s book on the international law of biotechnology.


View the whole table of content of EPLR 2/2020: Here

The European Pharmaceutical Law Review (EPLR) is seeking original research papers for a special issue on global pharmaceutical law and policy.

Please see for details our Special Call for Papers